Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast

ICL Announces Third Quarter 2021 Earnings Call


ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2021 results prior to the opening of the TASE market on Thursday, November 4, 2021.

On that day, Raviv Zoller, president and CEO of ICL, and Kobi Altman, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (12:30 p.m. London and 2:30 p.m. Tel Aviv).

The third quarter earnings call conference ID is 1488774, and analysts should use one of the below toll-free numbers to dial in a few minutes prior to the scheduled time.

Analysts may also access the call by dialing +44 (0) 207 192 8000 or online at https://investors.icl-group.com/reports-news-and-events/ by using the password November2021, if needed. Employees, the media and the public are also invited to join the call online. A replay of the call will be available online within approximately 24 hours of the live event.

About ICL

ICL Group is a leading global specialty minerals company, which also benefits from commodity upside. The company creates impactful solutions for humanity's sustainability challenges in global food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2020 revenues totaled approximately $5.0 billion.

For more information, visit ICL's website at www.icl-group.com.

To access ICL's interactive Corporate Social Responsibility report, please click here.

You can also learn more about ICL on Facebook, LinkedIn and Instagram.


These press releases may also interest you

at 09:17
Canadian Investment Regulatory Organization Trading Halt - MDCX
The following issues have been halted by CIRO Company: Medicus Pharma Ltd. TSX-Venture Symbol: MDCX  All Issues: Yes Reason: Pending News Halt Time (ET): 9:09 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 09:17
Risk3sixty Named a Pacesetter for the Sixth Consecutive Year
Risk3sixty, a leading cybersecurity technology and consulting firm, announced today that it has been named a Pacesetter Award winner by the Atlanta Business Chronicle for a sixth consecutive year. The Pacesetter Awards celebrate the 100...

at 09:15
Mullen Announces New CARB Approval for 2025 Class 3 EV Cab Chassis Truck
via IBN...

at 09:15
SEATTLE KRAKEN INCREASES BROADCAST AND STREAMING ACCESS THROUGH PARTNERSHIPS WITH TEGNA AND PRIME VIDEO
The Seattle Kraken today announced new multi-year agreements with TEGNA and Prime Video to offer more options for fans to watch their games throughout the Pacific Northwest....

at 09:15
Thirty Madison's Nurx and Cove partner with Talkspace to expand mental health support for more than half a million women
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for Neovascular AMD Treatment
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...

More news about Business...


News published on and distributed by: